Sonos launches Amp Multi streaming amplifier for large homes

Sonos (NASDAQ: SONO) announced the Amp Multi, a multi-channel streaming amplifier designed for residential audio installations in larger homes. The device features eight amplified outputs delivering 125 watts each and supports up to four configurable zones.

The amplifier can drive up to 24 Sonos Architectural speakers, with three speakers per channel. Any output can be assigned to any zone, and multiple units can be connected for larger installations. The device uses GaN power architecture combined with Class-D post-filter feedback technology.

"Sonos Amp is the most widely used two-channel streaming amplifier in residential installation because it's powerful, dependable, and intuitive," said Tom Conrad, CEO of Sonos. "Amp Multi takes that same philosophy and applies it to larger systems."

The product includes ProTune, a sound optimization tool that provides integrators with a 10-band parametric EQ, gain control, width control and delay offset for each output. The system operates without fans and features a 1.5U chassis designed for rack mounting.

The device includes an audible chirp feature triggered from the Sonos app to identify hardware during setup, eliminating manual PIN entry. A dedicated 2U rack mount is sold separately and creates ventilation space above and below each unit.

"We created Amp Multi with integrators at the heart of every decision, drawing on their deep understanding of real-world installation challenges," said Chris Heintzelman, VP of Product at Sonos.

Amp Multi will be available globally through Sonos installation partners in the coming months. Sonos will demonstrate the product at Integrated Systems Europe from February 3-6, 2026, at booth 1E500 in Hall 1.

You May Also Be Interested In

• Apple alleges defendant in trade secret case against OpenAI accessed power converter circuit schematic while at OpenAI - legal filing
• Tidewater completes acquisition of Wilson Sons Ultratug
• Teva in talks with Trump administration on Medicaid drug pricing